Thorsten Koch

2.3k total citations
8 papers, 213 citations indexed

About

Thorsten Koch is a scholar working on Oncology, Cancer Research and Epidemiology. According to data from OpenAlex, Thorsten Koch has authored 8 papers receiving a total of 213 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Cancer Research and 2 papers in Epidemiology. Recurrent topics in Thorsten Koch's work include HER2/EGFR in Cancer Research (4 papers), Breast Cancer Treatment Studies (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Thorsten Koch is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Breast Cancer Treatment Studies (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Thorsten Koch collaborates with scholars based in Germany, Austria and Switzerland. Thorsten Koch's co-authors include Alexander Dzien, Friedrich Hoppichler, Monika Lechleitner, Manfred Herold, Thomas Göhler, Gabriele Feisel-Schwickardi, Axel Hinke, Peter Dall, Helmut Eiffert and Matthias Spindler and has published in prestigious journals such as Cancer Research, Journal of Internal Medicine and The Oncologist.

In The Last Decade

Thorsten Koch

8 papers receiving 205 citations

Peers

Thorsten Koch

MB

ONCOL

EDM

GENET

IMMUN

Haïfa Sanhaji Tunisia

Hongming Pan China

Yen‐Bo Lin Taiwan

Kuan‐Yu Lin Taiwan

Giulietta A. Perrone Italy

Fahmida Rasha United States

Hongwei Yang China

Ani Shahbazian United States

Jingsong Shi China

Haïfa Sanhaji Tunisia

Thorsten Koch

69 ×1.2

MB

39 ×0.7

ONCOL

37 ×0.8

EDM

51 ×1.1

GENET

51 ×1.4

IMMUN

Citations per year, relative to Thorsten Koch Thorsten Koch (= 1×) peers Haïfa Sanhaji

Countries citing papers authored by Thorsten Koch

Since Specialization

Citations

This map shows the geographic impact of Thorsten Koch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thorsten Koch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thorsten Koch more than expected).

Fields of papers citing papers by Thorsten Koch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thorsten Koch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thorsten Koch. The network helps show where Thorsten Koch may publish in the future.

Co-authorship network of co-authors of Thorsten Koch

This figure shows the co-authorship network connecting the top 25 collaborators of Thorsten Koch. A scholar is included among the top collaborators of Thorsten Koch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thorsten Koch. Thorsten Koch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Dall, Peter, Thorsten Koch, Thomas Göhler, et al.. (2018). Trastuzumab without chemotherapy in the adjuvant treatment of breast cancer: subgroup results from a large observational study. BMC Cancer. 18(1). 51–51. 10 indexed citations

2.

Dall, Peter, Thorsten Koch, Thomas Göhler, et al.. (2017). Trastuzumab in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Results of a Prospective, Noninterventional Study on Routine Treatment Between 2006 and 2012 in Germany. The Oncologist. 22(2). 131–138. 9 indexed citations

3.

Rath, M, Lorenz Uhlmann, Joerg Heil, et al.. (2017). Oncotype DX® in breast cancer patients: clinical experience, outcome and follow-up—a case–control study. Archives of Gynecology and Obstetrics. 297(2). 443–447. 7 indexed citations

4.

Dall, Peter, Thomas Göhler, Christian Lerchenmüller, et al.. (2015). Trastuzumab in the treatment of elderly patients with early breast cancer: Results from an observational study in Germany. Journal of Geriatric Oncology. 6(6). 462–469. 19 indexed citations

5.

Dall, Peter, Thomas Göhler, Thorsten Koch, et al.. (2013). Abstract P2-15-02: Trastuzumab treatment of early breast cancer: Long-term results from a prospective observation study, including a large cohort of elderly patients. Cancer Research. 73(24_Supplement). P2–15. 2 indexed citations

6.

Hoppichler, Friedrich, et al.. (2000). Prognostic Value of Antibody Titre to Heat-Shock Protein 65 on Cardiovascular Events. Cardiology. 94(4). 220–223. 25 indexed citations

7.

Lechleitner, Monika, Thorsten Koch, Manfred Herold, Alexander Dzien, & Friedrich Hoppichler. (2000). Tumour necrosis factor‐alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors. Journal of Internal Medicine. 248(1). 67–76. 136 indexed citations

8.

Koch, Thorsten, Helmut Eiffert, & Matthias Spindler. (1989). [Relevance of the new tumor marker SCC (squamous cell carcinoma antigen) for the diagnosis and follow-up control of squamous epithelial carcinoma of the head and neck].. PubMed. 37(11). 454–9. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact